INFLUVAC TETRA

The Influvac Tetra 0.5ml Injection contains the active ingredient known as the influenza vaccine, which is designed primarily to provide protection against the influenza virus. This vaccine works by stimulating the body’s immune system to produce antibodies against the virus, thereby reducing the likelihood of infection. Even in cases where vaccinated individuals contract the flu, the vaccine often helps to lessen the intensity of the symptoms and shorten the duration of illness.

Influenza can pose serious health risks, particularly for vulnerable groups such as older adults, infants, pregnant women, and individuals suffering from chronic health conditions like asthma, diabetes, or heart disease. For these high-risk populations, vaccination serves as a crucial measure to prevent severe complications, minimize hospitalizations, and reduce the risk of death. On a larger scale, increasing flu vaccination coverage helps lower the overall transmission rate within communities, contributing to broader public health protection.

However, some individuals may be allergic to components within the vaccine, such as egg proteins or other ingredients. In cases where a person has experienced a severe allergic reaction to a previous dose of the Influvac Tetra vaccine, further administration may be contraindicated. Additionally, individuals with a history of Guillain-Barré syndrome should consult their healthcare provider before receiving the vaccine, as there is a noted, though rare, association between the condition and influenza immunization.

For individuals with kidney disease, the Influvac vaccine is considered safe and is not associated with increased risk. It is especially recommended for older adults, as they are more susceptible to serious complications from influenza, and vaccination offers an effective line of defense.